Search
for
Sort by
Research 151–180 of 1000+
- Novel anti-Mullerian hormone receptor 2 binding peptide prevents chemotherapy-related ovarian follicle loss in a mouse model
- Recent Progress and Morphological Distribution of Polydopamine-Based Biomaterials and Their Applications
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- II Nanosciesce and Nanotecnology Biomedicals Symposium - Proceedings
- Topical liposome delivery of molecules to hair follicles in mice
- Plants Producing Ribosome-Inactivating Proteins in Traditional Medicine
- Biomaterials Mimicking Mechanobiology: A Specific Design for a Specific Biological Application
- Prevalence of Cobalt in the Environment and Its Role in Biological Processes
- Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis
- Advances and Prospects for Hydrogel-Forming Microneedles in Transdermal Drug Delivery
- [ADRENOCORTICAL CARCINOMA].
- Role of DNA Methylation in the Pathogenesis of Skin Disorders: Mechanisms, Inhibitors of Methylation‐Related Enzyme, and Molecular Docking Studies
- Management of Breast Pain
- Protection against chemotherapy-induced alopecia: targeting ATP-binding cassette transporters in the hair follicle?
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Birt–Hogg–Dubé syndrome: from gene discovery to molecularly targeted therapies
- Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis
- Treatment and prevention of chemotherapy-induced alopecia with PTH-CBD, a collagen-targeted parathyroid hormone analog, in a non-depilated mouse model
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Basal Cell Carcinoma, Hedgehog Signaling, and Targeted Therapeutics: The Long and Winding Road
- Development and Evaluation of a Niosome-Integrated Microneedle System for Targeted Follicular Delivery of Ketoconazole in Alopecia Therapy
- Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Enhancing Cancer Therapy with Hyperthermia: Synergistic Effects with Natural Compounds and Conventional Treatments
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System